Growth & Returns

A landmark deal between IQE and Tower Semiconductor not only ends a bitter IP dispute but also secures a vital supply line for the optical chips powering the AI revolution.

While Nevada's cannabis market contracts, C21 Investments posts record customer growth and an 8% revenue jump, fueled by a high-stakes tax challenge.

With a high-yield dividend and perfect rent collection, NewLake Capital signals stability. But is this cannabis REIT a safe haven or just a high-risk reward?

A new app promises 'pure adrenaline' by turning every moment of a soccer match into a game. But is it harmless fun or a gateway to the next frontier of gambling?

How one imaging company is challenging sports photography norms by investing in the creator economy and the powerful stories hidden beyond the final score.

A local bank awarded 10 scholarships from 340+ applicants. It's not just goodwill; it's a strategic investment in human capital addressing a critical gap.

As Xtract One woos investors in Vegas, its AI security tech promises safety without sacrificing freedom. But can it scale its vision of a frictionless world?

With its new Series A, Aton Health isn't just growing; it's validating a model where research is seamlessly integrated into routine patient care.

Hisense's dazzling World Cup pop-up at Hudson Yards offers fans a tech-fueled fantasy. But beneath the surface lies a calculated play for market dominance.

As Ottawa rolls out a new food strategy, Pamela Cox examines whether it can fix a broken system of soaring costs and deep-seated insecurity for millions.

As FIFA World Cup 2026 kicks off, Hisense is executing a masterclass in market disruption, using the global stage to redefine the TV landscape with RGB MiniLED.

Leveraged finance titans turned a personal fight into a philanthropic powerhouse, raising a record $4.3M to fund the science that’s turning the tide on melanoma.

The Jim Henson Company's 'Monster Dance' uses cutting-edge tech and creative choreography to teach kids emotional literacy. It's more than a show; it's a new paradigm.

A new report forecasts a $500B 6G market by 2034, but operators are tapping the brakes. Here’s why the 5G hangover means a more pragmatic, evolutionary path ahead.

A projected 14.9% CAGR signals a gold rush in Alzheimer's agitation treatment. New, safer drugs are replacing risky antipsychotics, offering hope to millions.

Don't be fooled by layoff headlines. New data reveals AI is driving a surge in tech hiring in unexpected sectors, but a shrinking applicant pool is creating a crisis.

The battle for brand visibility has moved to a new front: AI answers. As tools like ChatGPT become gatekeepers, companies must learn to speak their language.

A new GNSS module from Telit Cinterion offers a seamless upgrade path for legacy IoT devices, solving a major industry headache and quietly powering our future.

With a promising cancer therapy but precarious finances, Propanc Biopharma's stock buyback raises a critical question: is it a sign of confidence or a high-stakes gamble?

As global executives gather in Qingdao, the summit reveals China's new playbook: a targeted bid for high-tech MNEs to fuel its 15th Five-Year Plan.